Serologic and fecal markers to predict response to induction therapy in dogs with idiopathic inflammatory bowel disease.
Cristiane C OtoniRomy M HeilmannMercedes García-SanchoAngel SainzMark R AckermannJan S SuchodolskiJörg M SteinerAlbert E JergensPublished in: Journal of veterinary internal medicine (2018)
Our data indicate that measurement of fecal cCP concentration is a useful biomarker for noninvasive evaluation of intestinal inflammation. Dogs with severe signs of GI disease more often have abnormal markers than dogs having less severe disease.